Our Science

Resistance-informed target selection
Identifying tumor vulnerabilities shaped by cancer evolution, heterogeneity, and treatment resistance.

Next-generation payload strategies
Exploring payload innovations to deepen response, overcome resistance, and improve therapeutic durability.

Translationally guided development
Integrating biomarker expression, internalization biology, tumor indication selection, and clinical unmet need to guide program prioritization.